News | July 15, 2014

Sun Nuclear Announces Acquisition Agreement with Gammex Inc.

July 15, 2014 — Sun Nuclear Corp. announced its intended acquisition of Gammex Inc., which became effective July 2. The acquisition combines two complementary product lines within the radiation oncology marketplace, and adds diagnostic radiology quality assurance (QA) capability to Sun Nuclear's therapeutic radiation oncology QA and dosimetry position.

"I am excited to see these two companies combine because of their deep synergies," said Margaret Lescrenier, president of Gammex Inc. "We started Gammex in 1969 and have been pioneers in radiation oncology and diagnostic products for over 40 years. We see a promising future for continued innovation and growth of the Gammex product line under the new leadership of SNC."

"We are very excited to bring Gammex into the Sun Nuclear family," says Jeff Simon, CEO of Sun Nuclear. "Gammex has a long history of meaningful innovation and technical expertise that fits perfectly with Sun Nuclear's core values and mission. We believe Gammex is a company of great opportunity, and look forward to providing the market leadership in quality assurance and patient safety that Sun Nuclear is known for today, and to continue Gammex's rich history of innovation. We are also excited to make this investment in Middleton (Madison) Wisconsin, a recognized world leader in the medical physics and cancer care industry, and home to the University of Wisconsin."

For more information: www.sunnuclear.com, www.gammex.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init